Cross-reference to form 20-F
The information in this document that is referenced on this page is included in AstraZeneca’s Form 20-F for 2007 (2007 Form 20-F) and is filed with the Securities and Exchange Commission (SEC). The 2007 Form 20-F is the only document intended to be incorporated by reference into any filings by AstraZeneca under the Securities Act of 1933, as amended. References to major headings include all information under such major headings, including subheadings. References to subheadings include only the information contained under such subheadings. Graphs are not included unless specifically identified. The 2007 Form 20-F has not been approved or disapproved by the SEC, nor has the SEC passed comment upon the accuracy or adequacy of the 2007 Form 20-F. The 2007 Form 20-F filed with the SEC may contain modified information and may be updated from time to time.
3 KEY INFORMATION
| A. | Selected financial data |
| Financial Highlights | |
| Group Financial Record | |
| Shareholder Information | |
| D. | Risk |
4 INFORMATION ON THE COMPANY
| A. | History and development of the Company |
| Financial Review – Investments, divestments and capital expenditure | |
| Note 8 – Property, plant and equipment | |
| Note 24 – Acquisitions of business operations | |
| B. | Business overview |
| Directors’ Report | |
| C. | Organisational structure |
| Directors’ Report – Corporate Governance and Managing Risk | |
| Principal Subsidiaries | |
| D. | Property, plant and equipment |
| Directors’ Report – Main Facilities |
5 OPERATING AND FINANCIAL REVIEW AND PROSPECTS
| A-F. | Directors’ Report |
| A-F. | Financial Review |
| Note 17 – Financial instruments |
6 DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES
7 MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS
| A. | Major shareholders |
| Shareholder Information – Major shareholdings | |
| B. | Related party transactions |
| Shareholder Information – Related party transactions | |
| Note 29 – Statutory and other information |
8 FINANCIAL INFORMATION
| A. | Consolidated statements and other financial information |
| Financial Statements (excluding Directors’ responsibilities and Auditors’ opinion) | |
| B. | Significant changes |
| Note 29 – Statutory and other information |
9 THE OFFER AND LISTING
| A4. | Price history of listed stock |
| Shareholder Information | |
| C. | Markets |
| Shareholder Information |
10 ADDITIONAL INFORMATION
| B. | Memorandum and Articles of Association | |
| C. | Material contracts | n/a |
| D. | Exchange controls and other limitations affecting security holders | |
| E. | Taxation | |
| H. | Documents on display | |
| I. | Subsidiary information | |
| Principal Subsidiaries |
11 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
| Financial Review – Financial Risk Management Policies – Treasury |
12 DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES
n/a
13 DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES
n/a
14 MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS
n/a
15 CONTROLS AND PROCEDURES
| Directors’ Report – Internal controls, risk management and Turnbull Report guidance |
16 [RESERVED]
| A. | Audit Committee financial expert | |
| Audit Committee | ||
| B. | Code of ethics | |
| Directors’ Report – Code of Conduct | ||
| C. | Principal accountant fees and services | |
| Note 29 – Statutory and other information | ||
| D. | Exemptions from the listing standards for audit committees | n/a |
| E. | Purchases of equity securities by the issuer and affiliated purchasers | |
| Note 30 – Share capital of parent company |
18 FINANCIAL STATEMENTS
| Financial Statements (excluding Directors’ responsibilities and Auditors’ opinion) |
